Thursday , 19 September 2024
Home Innovation Healthcare Lawsuits Claim Baby Bottle Makers Misled on Microplastic Risks
Healthcare

Lawsuits Claim Baby Bottle Makers Misled on Microplastic Risks

feeding baby with bottle of milk

Philips North America and Handi-Craft Company, the parent company of Dr. Brown’s Baby, face separate lawsuits filed Tuesday alleging that their baby bottles, marketed as ‘BPA free,’ mislead consumers by not disclosing potential exposure to toxic microplastics when heated. The class action suits, filed by California-based Clarkson Law Firm, contend that the companies failed to adequately warn caregivers and parents about the alleged release of harmful chemicals into food and drinks when their bottles are heated.

The lawsuits argue that despite the ‘BPA free’ labels, which suggest safety from harmful chemicals, both Philips and Dr. Brown’s Baby bottles are made from polypropylene, a type of microplastic. This material, according to the suits, can seep into contents when exposed to heat, posing risks to infants and children. While the companies disclose the use of polypropylene on their websites, the suits claim this information is not prominently displayed on product packaging where consumers expect clear safety disclosures.

Citing various studies, the suits highlight potential health risks associated with microplastic exposure in young children, including impacts on digestive, immune, reproductive, central nervous, and circulatory systems. The lawsuits argue that the ‘BPA free’ label may mislead consumers by implying a higher standard of safety than what is actually provided, given the potential risks associated with microplastic exposure.

BPA, a chemical previously common in plastics, was banned from baby bottles and cups by the FDA in 2012 due to health concerns related to leaching into food. Since then, polypropylene has become a popular alternative in baby bottle manufacturing, accounting for a significant portion of global sales. Studies referenced in the suits indicate that heating polypropylene bottles can release significant amounts of microplastics, potentially exposing infants to millions of particles per liter, including smaller nanoplastics.

Clarkson Law Firm seeks monetary compensation, including restitution, punitive damages, and penalties, on behalf of affected consumers. They demand that manufacturers either prominently disclose the use of polypropylene on product labels, modify the bottles to prevent microplastic release, or discontinue their sale altogether.

Shireen Clarkson, partner at Clarkson Law Firm, expressed concern over the alleged lack of transparency regarding product safety: ‘As a mother, it’s incredibly concerning that companies claiming to prioritize children’s safety may be downplaying the risks of their products for profit. These companies must be held accountable, and parents need clear information about the potential dangers.’

In contrast, organizations like the American Academy of Pediatrics advocate for polypropylene baby bottles as a safe alternative to BPA-containing plastics, noting FDA approval for food contact and its perceived safety relative to other plastics due to its heat-resistant properties. Clean Product Action, a nonprofit group, has also identified polypropylene as among the ‘most benign’ plastics in terms of environmental and health impacts.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Mounjaro
Healthcare

Women Lose More Weight on Mounjaro, Zepbound

Recent research has shed new light on the weight loss effects of...

music festival
Healthcare

Valley Fever Outbreak at California Festival

California health officials are bracing for a potential rise in valley fever...

Ozempic, Wegovy, Mounjaro, and Zepbound
Healthcare

New Benefits of Ozempic, Wegovy, Mounjaro, and Zepbound

Recent research has illuminated the expanding potential of drugs such as Ozempic,...

Novavax vaccine
Healthcare

FDA Approves Novavax COVID Vaccine After Pfizer and Moderna

On Friday, the Food and Drug Administration (FDA) granted approval for an...